Progressive Care Inc (RXMD)

[stockforce]

The Congressional Research Service (CRS), for its part, said in September that it was “likely” DEA would follow the HHS recommendation, at least based on past precedent.

https://www.marijuanamoment.net/feds-release-marijuana-documents-confirming-schedule-iii-recommendation-based-on-accepted-medical-use/

Once approved by DEA, "any controlled substance listed in Schedule III or Schedule IV may be dispensed by a pharmacist upon an oral prescription if, before filling the prescription, the pharmacist reduces it to writing or records the prescription electronically if permitted by federal law. Such prescriptions must contain the date of the oral authorization."

https://www.floridahealth.gov/licensing-and-regulation/counterfeit-proof-prescription-pad-vendors/faq.html#:~:text=Any%20controlled%20substance%20listed%20in,if%20permitted%20by%20federal%20law.

RXMD Therapeutics, Inc. was established in 2019 for CBD products. They have been waiting just for this change on a federal level so they can sell CBD products as schedule III substance as a pharmacy. The revenue potential is extremely huge for them.